{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T02:42:49Z","timestamp":1792636969168,"version":"4.5.0"},"reference-count":101,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2002,2,1]],"date-time":"2002-02-01T00:00:00Z","timestamp":1012521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2002,2]]},"DOI":"10.4065\/77.2.181","type":"journal-article","created":{"date-parts":[[2009,1,24]],"date-time":"2009-01-24T01:19:36Z","timestamp":1232759976000},"page":"181-187","source":"Crossref","is-referenced-by-count":26,"title":["Acquired von Willebrand Disease"],"prefix":"10.4065","volume":"77","author":[{"given":"Shaji","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiv K.","family":"Pruthi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William L.","family":"Nichols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.4065\/77.2.181_bib1","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1182\/blood.V69.2.454.454","article-title":"Epidemiological investigation of the prevalence of von Willebrand's disease","volume":"69","author":"Rodeghiero","year":"1987","journal-title":"Blood"},{"key":"10.4065\/77.2.181_bib2","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1182\/blood.V31.6.806.806","article-title":"Acquired von Willebrand's syndrome in systemic lupus erythematosus","volume":"31","author":"Simone","year":"1968","journal-title":"Blood"},{"key":"10.4065\/77.2.181_bib3","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/S0002-9343(97)00239-8","article-title":"Acquired von Willebrand disease: concise review of occurrence, diagnosis, pathogenesis, and treatment","volume":"103","author":"Tefferi","year":"1997","journal-title":"Am J Med"},{"key":"10.4065\/77.2.181_bib4","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2141.1971.tb03429.x","article-title":"Four cases of acquired von Willebrand's syndrome","volume":"21","author":"Ingram","year":"1971","journal-title":"Br J Haematol"},{"key":"10.4065\/77.2.181_bib5","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1182\/blood.V48.3.393.393","article-title":"Antibody-induced von Willebrand's disease: a newly defined inhibitor syndrome","volume":"48","author":"Handin","year":"1976","journal-title":"Blood"},{"key":"10.4065\/77.2.181_bib6","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1055\/s-0037-1614018","article-title":"Acquired von Willebrand syndrome: data from an international registry","volume":"84","author":"Federici","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.4065\/77.2.181_bib7","first-page":"213","article-title":"Estimation of prevalence and natural history of acquired von Willebrand disease [abstract]","volume":"6","author":"Kumar","year":"2000","journal-title":"Haemophilia"},{"key":"10.4065\/77.2.181_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V58.1.1.1","article-title":"The factor VIII complex: structure and function","volume":"58","author":"Hoyer","year":"1981","journal-title":"Blood"},{"key":"10.4065\/77.2.181_bib9","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1600-0609.1976.tb01127.x","article-title":"Acquired von Willebrand's syndrome and thrombopathy in a patient with chronic lymphocytic leukaemia","volume":"16","author":"Wautier","year":"1976","journal-title":"Scand J Haematol"},{"key":"10.4065\/77.2.181_bib10","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1365-2141.1988.tb06194.x","article-title":"Acquired type II von Willebrand's disease: demonstration of a complexed inhibitor of the von Willebrand factor-platelet interaction and response to treatment","volume":"68","author":"Goudemand","year":"1988","journal-title":"Br J Haematol"},{"key":"10.4065\/77.2.181_bib11","first-page":"1093","article-title":"Acquired von Willebrand's disease in chronic lymphatic leukemia [in Danish]","volume":"148","author":"Cold","year":"1986","journal-title":"Ugeskr Laeger"},{"key":"10.4065\/77.2.181_bib12","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1365-2141.1980.tb06001.x","article-title":"Acquired Von Willebrand's syndrome associated with hairy cell leukaemia","volume":"46","author":"Roussi","year":"1980","journal-title":"Br J Haematol"},{"key":"10.4065\/77.2.181_bib13","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1056\/NEJM197805042981802","article-title":"Acquired von Willebrand's disease: evidence for a quantitative and qualitative factor VIII disorder","volume":"298","author":"Joist","year":"1978","journal-title":"N Engl J Med"},{"key":"10.4065\/77.2.181_bib14","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1046\/j.1365-2141.1997.d01-2088.x","article-title":"Acquired von Willebrand's disease due to aberrant expression of platelet glycoprotein Ib by marginal zone lymphoma cells","volume":"96","author":"Tefferi","year":"1997","journal-title":"Br J Haematol"},{"key":"10.4065\/77.2.181_bib15","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1182\/blood.V84.10.3378.3378","article-title":"Acquired von Willebrand disease caused by an autoantibody selectively inhibiting the binding of von Willebrand factor to collagen","volume":"84","author":"van Genderen","year":"1994","journal-title":"Blood"},{"key":"10.4065\/77.2.181_bib16","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1182\/blood.V92.8.2707","article-title":"Treatment of acquired von Willebrand syndrome in patients with monoclonal gammopathy of uncertain significance: comparison of three different therapeutic approaches","volume":"92","author":"Federici","year":"1998","journal-title":"Blood"},{"key":"10.4065\/77.2.181_bib17","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/BF02937942","article-title":"Acquired von Willebrand's disease","volume":"167","author":"Hennessy","year":"1998","journal-title":"Ir J Med Sci"},{"key":"10.4065\/77.2.181_bib18","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1055\/s-0038-1650099","article-title":"Acquired von Willebrand's syndrome in the course of Waldenstrom's disease","volume":"44","author":"Mazurier","year":"1980","journal-title":"Thromb Haemost"},{"key":"10.4065\/77.2.181_bib19","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1365-2141.1983.tb02091.x","article-title":"Acquired von Willebrand's disease: demonstration of a circulating inhibitor to the factor VIII complex in four cases","volume":"54","author":"Sampson","year":"1983","journal-title":"Br J Haematol"},{"key":"10.4065\/77.2.181_bib20","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/ajcp\/85.1.115","article-title":"A human myeloma-produced monoclonal protein directed against the active subpopulation of von Willebrand factor","volume":"85","author":"Bovill","year":"1986","journal-title":"Am J Clin Pathol"},{"key":"10.4065\/77.2.181_bib21","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/00001721-199509000-00010","article-title":"Acquired von Willebrand disease associated with multiple myeloma: characterization of an inhibitor to von Willebrand factor","volume":"6","author":"Mohri","year":"1995","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.4065\/77.2.181_bib22","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1365-2141.1981.tb02700.x","article-title":"Acquired von Willebrand's disease caused by a chronic granulocytic leukaemia","volume":"48","author":"Duran-Saurez","year":"1981","journal-title":"Br J Haematol"},{"key":"10.4065\/77.2.181_bib23","first-page":"123","article-title":"Acquired type 2A von Willebrand disease in chronic myelocytic leukemia","volume":"10","author":"Mohri","year":"1996","journal-title":"Hematopathol Mol Hematol"},{"key":"10.4065\/77.2.181_bib24","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/ajh.2830220408","article-title":"Acquired von Willebrand disease and storage pool disease in chronic myelocytic leukemia","volume":"22","author":"Mohri","year":"1986","journal-title":"Am J Hematol"},{"key":"10.4065\/77.2.181_bib25","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1159\/000204725","article-title":"Acquired von Willebrand's disease in association with essential thrombocythemia: regression following treatment","volume":"87","author":"Murakawa","year":"1992","journal-title":"Acta Haematol"},{"key":"10.4065\/77.2.181_bib26","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1093\/ajcp\/88.1.102","article-title":"Essential thrombocythemia with acquired von Willebrand's disease","volume":"88","author":"Raman","year":"1987","journal-title":"Am J Clin Pathol"},{"key":"10.4065\/77.2.181_bib27","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/ajh.2830260204","article-title":"Acquired von Willebrand disease in patients with polycythemia rubra vera","volume":"26","author":"Mohri","year":"1987","journal-title":"Am J Hematol"},{"key":"10.4065\/77.2.181_bib28","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/ajh.2830210310","article-title":"Acquired von Willebrand syndrome due to an inhibitor specific for von Willebrand factor antigens","volume":"21","author":"Lazarchick","year":"1986","journal-title":"Am J Hematol"},{"key":"10.4065\/77.2.181_bib29","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/S0022-3476(79)80293-0","article-title":"Acquired von Willebrand disease in a patient with Wilms tumor","volume":"95","author":"Noronha","year":"1979","journal-title":"J Pediatr"},{"key":"10.4065\/77.2.181_bib30","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/(SICI)1096-911X(199604)26:4<238::AID-MPO3>3.0.CO;2-K","article-title":"Acquired Von Willebrand disease in children with a Wilms' tumor","volume":"26","author":"Jonge Poerink-Stockschlader","year":"1996","journal-title":"Med Pediatr Oncol"},{"key":"10.4065\/77.2.181_bib31","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1200\/JCO.1992.10.3.422","article-title":"Acquired von Willebrand disease in Wilms' tumor patients","volume":"10","author":"Coppes","year":"1992","journal-title":"J Clin Oncol"},{"key":"10.4065\/77.2.181_bib32","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.1365-2141.1992.tb04562.x","article-title":"Acquired type II von Willebrand's disease associated with adrenal cortical carcinoma","volume":"80","author":"Facon","year":"1992","journal-title":"Br J Haematol"},{"key":"10.4065\/77.2.181_bib33","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/ajh.2830400214","article-title":"Acquired von Willebrand disease: correction of hemostatic defect by high-dose intravenous immunoglobulins","volume":"40","author":"Delmer","year":"1992","journal-title":"Am J Hematol"},{"key":"10.4065\/77.2.181_bib34","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/mpo.2950250213","article-title":"Acquired von Willebrand disease in malignant peripheral neuroectodermal tumor (PNET)","volume":"25","author":"Nowak-Gottl","year":"1995","journal-title":"Med Pediatr Oncol"},{"key":"10.4065\/77.2.181_bib35","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1182\/blood.V91.10.3623","article-title":"Clinical significance of inhibitors in acquired von Willebrand syndrome","volume":"91","author":"Mohri","year":"1998","journal-title":"Blood"},{"key":"10.4065\/77.2.181_bib36","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/ajh.2830460216","article-title":"Acquired von Willebrand's syndrome in association with a lupus-like anticoagulant corrected by intravenous immunoglobulin","volume":"46","author":"Hanley","year":"1994","journal-title":"Am J Hematol"},{"key":"10.4065\/77.2.181_bib37","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1365-2141.1999.01360.x","article-title":"Three cases of acquired von Willebrand disease associated with systemic lupus erythematosus","volume":"105","author":"Viallard","year":"1999","journal-title":"Br J Haematol"},{"key":"10.4065\/77.2.181_bib38","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0002-9343(88)90607-9","article-title":"Development of acquired von Willebrand's disease after mixed connective tissue disease","volume":"85","author":"Yoshida","year":"1988","journal-title":"Am J Med"},{"key":"10.4065\/77.2.181_bib39","first-page":"212","article-title":"Acquired von Willebrand's syndrome during collagen disorder (author's transl) [in Italian]","volume":"59","author":"Leone","year":"1974","journal-title":"Haematologica"},{"key":"10.4065\/77.2.181_bib40","first-page":"1493","article-title":"Acquired von Willebrand syndrome with autoimmune hemolytic anemia [in Japanese]","volume":"31","author":"Ishimaru","year":"1990","journal-title":"Rinsho Ketsueki"},{"key":"10.4065\/77.2.181_bib41","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1046\/j.1365-2516.1999.00340.x","article-title":"Acquired von Willebrand syndrome\u2014report of 10 cases and review of the literature","volume":"5","author":"Nitu-Whalley","year":"1999","journal-title":"Haemophilia"},{"key":"10.4065\/77.2.181_bib42","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0022-3476(05)82007-4","article-title":"Acquired von Willebrand disease in twins with autoimmune hypothyroidism: response to desmopressin and L-thyroxine therapy","volume":"125","author":"Bruggers","year":"1994","journal-title":"J Pediatr"},{"key":"10.4065\/77.2.181_bib43","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1365-2141.1976.tb03575.x","article-title":"Acquired von Willebrand syndrome with inhibitors both to factor VIII clotting activity and ristocetin-induced platelet aggregation","volume":"33","author":"Stableforth","year":"1976","journal-title":"Br J Haematol"},{"key":"10.4065\/77.2.181_bib44","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/ajh.2830490114","article-title":"Characterization of two cases of acquired transitory von Willebrand syndrome with ciprofloxacin: evidence for heightened proteolysis of von Willebrand factor","volume":"49","author":"Castaman","year":"1995","journal-title":"Am J Hematol"},{"key":"10.4065\/77.2.181_bib45","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/0140-6736(90)91235-3","article-title":"Induction of von Willebrand disease type I by valproic acid","volume":"335","author":"Kreuz","year":"1990","journal-title":"Lancet"},{"key":"10.4065\/77.2.181_bib46","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2257.1992.tb00367.x","article-title":"Hydroxyethyl starch induced acquired von Willebrand's disease","volume":"14","author":"Dalrymple-Hay","year":"1992","journal-title":"Clin Lab Haematol"},{"key":"10.4065\/77.2.181_bib47","first-page":"306","article-title":"The effect of 6% hydroxyethyl starch and desmopressin infusion on von Willebrand factor: ristocetin cofactor activity","volume":"25","author":"Lazarchick","year":"1995","journal-title":"Ann Clin Lab Sci"},{"key":"10.4065\/77.2.181_bib48","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1046\/j.1365-2141.1996.d01-1683.x","article-title":"Acquired von Willebrand factor deficiency during high-dose infusion of recombinant factor VIII","volume":"93","author":"Rock","year":"1996","journal-title":"Br J Haematol"},{"key":"10.4065\/77.2.181_bib49","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/ajh.2830410218","article-title":"Acquired von Willebrand's disease, IgE polyclonal gammopathy and griseofulvin therapy","volume":"41","author":"Conrad","year":"1992","journal-title":"Am J Hematol"},{"key":"10.4065\/77.2.181_bib50","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1016\/S0022-5347(01)62286-9","article-title":"Embryonal adenoma of the kidney associated with polycythemia and von Willebrand disease","volume":"160","author":"Konety","year":"1998","journal-title":"J Urol"},{"key":"10.4065\/77.2.181_bib51","first-page":"343","article-title":"Willebrand syndrome acquired during an amylosis of primitive appearance [in French]","volume":"26","author":"Tobelem","year":"1984","journal-title":"Nouv Rev Fr Hematol"},{"key":"10.4065\/77.2.181_bib52","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/(SICI)1096-8652(199902)60:2<151::AID-AJH13>3.0.CO;2-J","article-title":"Idiopathic immune-mediated acquired von Willebrand's disease in a patient with angiodysplasia: demonstration of an unusual inhibitor causing a functional defect and rapid clearance of von Willebrand factor","volume":"60","author":"Alhumood","year":"1999","journal-title":"Am J Hematol"},{"key":"10.4065\/77.2.181_bib53","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/0002-9343(78)90698-8","article-title":"Acquired von Willebrand's disease, platelet-release defect and angiodysplasia","volume":"65","author":"Rosborough","year":"1978","journal-title":"Am J Med"},{"key":"10.4065\/77.2.181_bib54","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/ajcp\/93.3.395","article-title":"Abnormality of von Willebrand factor in patients with hemoglobin E-beta (0) thalassemia","volume":"93","author":"Benson","year":"1990","journal-title":"Am J Clin Pathol"},{"key":"10.4065\/77.2.181_bib55","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1600-0609.1979.tb00424.x","article-title":"Acquired von Willebrand's syndrome and Ehlers-Danlos syndrome presenting with gastro-intestinal bleeding","volume":"22","author":"Clough","year":"1979","journal-title":"Scand J Haematol"},{"key":"10.4065\/77.2.181_bib56","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/j.1365-2141.1992.tb03005.x","article-title":"Acquired von Willebrand's disease due to excessive fibrinolysis","volume":"81","author":"Eikenboom","year":"1992","journal-title":"Br J Haematol"},{"key":"10.4065\/77.2.181_bib57","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0022-3476(05)82413-8","article-title":"Acquired von Willebrand disease after Epstein-Barr virus infection","volume":"119","author":"Kinoshita","year":"1991","journal-title":"J Pediatr"},{"key":"10.4065\/77.2.181_bib58","first-page":"211","article-title":"Acquired von Willebrand's disease following bone marrow transplantation","volume":"24","author":"Lazarchick","year":"1994","journal-title":"Ann Clin Lab Sci"},{"key":"10.4065\/77.2.181_bib59","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1055\/s-0038-1661144","article-title":"Acquired von Willebrand's syndrome associated with hydatid disease of the spleen\u2014disappearance after splenectomy","volume":"52","author":"Richard","year":"1984","journal-title":"Thromb Haemost"},{"key":"10.4065\/77.2.181_bib60","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1055\/s-0038-1654065","article-title":"Production site of bleeding factor (acquired morbus von Willebrand)","volume":"23","author":"Veltkamp","year":"1970","journal-title":"Thromb Diath Haemorrh"},{"key":"10.4065\/77.2.181_bib61","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1055\/s-2007-996119","article-title":"Acquired von Willebrand disease in patients with high platelet counts","volume":"23","author":"Budde","year":"1997","journal-title":"Semin Thromb Hemost"},{"key":"10.4065\/77.2.181_bib62","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/0049-3848(80)90223-6","article-title":"The bleeding diathesis in human glycogen storage disease type I: in vitro identification of a naturally occurring inhibitor of ristocetin-induced platelet aggregation","volume":"18","author":"Kao","year":"1980","journal-title":"Thromb Res"},{"key":"10.4065\/77.2.181_bib63","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1182\/blood.V68.1.180.180","article-title":"DDAVP infusion in five patients with type Ia glycogen storage disease and associated correction of prolonged bleeding times","volume":"68","author":"Marti","year":"1986","journal-title":"Blood"},{"key":"10.4065\/77.2.181_bib64","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/S0002-9343(88)80025-1","article-title":"Plasma and platelet von Willebrand factor defects in uremia","volume":"85","author":"Gralnick","year":"1988","journal-title":"Am J Med"},{"key":"10.4065\/77.2.181_bib65","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1056\/NEJM198107163050303","article-title":"von Willebrand syndromes and mitral-valve prolapse: linked mesenchymal dysplasias","volume":"305","author":"Pickering","year":"1981","journal-title":"N Engl J Med"},{"key":"10.4065\/77.2.181_bib66","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1182\/blood.V67.3.758.758","article-title":"Loss of the largest von Willebrand factor multimers from the plasma of patients with congenital cardiac defects","volume":"67","author":"Gill","year":"1986","journal-title":"Blood"},{"key":"10.4065\/77.2.181_bib67","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1182\/blood.V71.6.1648.1648","article-title":"Changes in von Willebrand factor during cardiac surgery: effect of desmopressin acetate","volume":"71","author":"Weinstein","year":"1988","journal-title":"Blood"},{"key":"10.4065\/77.2.181_bib68","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1182\/blood.V64.3.614.614","article-title":"Studies of the pathophysiology of acquired von Willebrand's disease in seven patients with lymphoproliferative disorders or benign monoclonal gammopathies","volume":"64","author":"Mannucci","year":"1984","journal-title":"Blood"},{"key":"10.4065\/77.2.181_bib69","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1159\/000206119","article-title":"Acquired type I von Willebrand's disease with essential thrombocytosis","volume":"75","author":"Casonato","year":"1986","journal-title":"Acta Haematol"},{"key":"10.4065\/77.2.181_bib70","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1182\/blood.V64.5.981.981","article-title":"Acquired von Willebrand's disease in the myeloproliferative syndrome","volume":"64","author":"Budde","year":"1984","journal-title":"Blood"},{"key":"10.4065\/77.2.181_bib71","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1365-2257.1988.tb01190.x","article-title":"Multimeric composition of plasma von Willebrand factor in chronic myeloproliferative disorders","volume":"10","author":"Tatewaki","year":"1988","journal-title":"Clin Lab Haematol"},{"key":"10.4065\/77.2.181_bib72","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1093\/ajcp\/87.5.663","article-title":"Acquired von Willebrand disease due to inhibitor of human myeloma protein specific for von Willebrand factor","volume":"87","author":"Mohri","year":"1987","journal-title":"Am J Clin Pathol"},{"key":"10.4065\/77.2.181_bib73","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1182\/blood.V66.3.562.562","article-title":"Comparison of inhibitory and binding characteristics of an antibody causing acquired von Willebrand syndrome: an assay for von Willebrand factor binding by antibody","volume":"66","author":"Fricke","year":"1985","journal-title":"Blood"},{"key":"10.4065\/77.2.181_bib74","first-page":"230","article-title":"Puerperal acquired factor VIII inhibitor causing a von Willebrand-like syndrome in a patient with anti-DNA antibodies","volume":"36","author":"Jackson","year":"1995","journal-title":"Singapore Med J"},{"key":"10.4065\/77.2.181_bib75","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1159\/000205889","article-title":"Acquired von Willebrand's syndrome due to an inhibitor of IgG specific for von Willebrand's factor in polycythemia rubra vera","volume":"78","author":"Mohri","year":"1987","journal-title":"Acta Haematol"},{"key":"10.4065\/77.2.181_bib76","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.0954-6820.1978.tb08484.x","article-title":"Acquired von Willebrand's disease caused by a monoclonal antibody","volume":"204","author":"Zettervall","year":"1978","journal-title":"Acta Med Scand"},{"key":"10.4065\/77.2.181_bib77","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1136\/jcp.32.10.1030","article-title":"Acquired von Willebrand's syndrome with IgM inhibitor against von Willebrand's factor","volume":"32","author":"Gouault-Heilmann","year":"1979","journal-title":"J Clin Pathol"},{"key":"10.4065\/77.2.181_bib78","first-page":"287","article-title":"Acquired von Willebrand's syndrome associated with decrease of plasminogen activator and its inhibitor during hypothyroidism","volume":"2","author":"Levesque","year":"1993","journal-title":"Eur J Med"},{"key":"10.4065\/77.2.181_bib79","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/0049-3848(90)90417-B","article-title":"Qualitative and quantitative abnormalities of von Willebrand antigen in patients with diabetes mellitus","volume":"59","author":"Pasi","year":"1990","journal-title":"Thromb Res"},{"key":"10.4065\/77.2.181_bib80","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1172\/JCI111628","article-title":"Carbohydrate moiety of von Willebrand factor is not necessary for maintaining multimeric structure and ristocetin cofactor activity but protects from proteolytic degradation","volume":"74","author":"Federici","year":"1984","journal-title":"J Clin Invest"},{"key":"10.4065\/77.2.181_bib81","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1182\/blood.V79.1.38.38","article-title":"Proteolysis of von Willebrand factor after thrombolytic therapy in patients with acute myocardial infarction","volume":"79","author":"Federici","year":"1992","journal-title":"Blood"},{"key":"10.4065\/77.2.181_bib82","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/ajh.2830350210","article-title":"Acquired von Willebrand disease in multiple myeloma secondary to absorption of von Willebrand factor by plasma cells","volume":"35","author":"Richard","year":"1990","journal-title":"Am J Hematol"},{"key":"10.4065\/77.2.181_bib83","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1056\/NEJM197902223000806","article-title":"A hemorrhagic syndrome in Waldenstrom's macroglobulinemia secondary to immunoadsorption of factor VIII: recovery after splenectomy","volume":"300","author":"Brody","year":"1979","journal-title":"N Engl J Med"},{"key":"10.4065\/77.2.181_bib84","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1365-2141.1993.tb03103.x","article-title":"Expression of GpIb on plasma cells in a patient with monoclonal IgG and acquired von Willebrand disease","volume":"84","author":"Scrobohaci","year":"1993","journal-title":"Br J Haematol"},{"key":"10.4065\/77.2.181_bib85","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1093\/ajcp\/92.4.471","article-title":"Absence of a bleeding tendency in severe acquired von Willebrand's disease: the role of platelet von Willebrand factor in maintaining normal hemostasis","volume":"92","author":"Drouin","year":"1989","journal-title":"Am J Clin Pathol"},{"key":"10.4065\/77.2.181_bib86","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1182\/blood.V69.6.1691.1691","article-title":"The effect of ABO blood group on the diagnosis of von Willebrand disease","volume":"69","author":"Gill","year":"1987","journal-title":"Blood"},{"key":"10.4065\/77.2.181_bib87","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1182\/blood.V73.4.990.990","article-title":"Possible effect of secretor locus on plasma concentration of factor VIII and von Willebrand factor","volume":"73","author":"Orstavik","year":"1989","journal-title":"Blood"},{"issue":"suppl","key":"10.4065\/77.2.181_bib88","first-page":"196a","article-title":"The von Willebrand factor propolypeptide, von Willebrand antigen II (vWAgII), distinguishes acquired von Willebrand syndrome (AvWS) due to decreased synthesis of von Willebrand factor (vWF) from AvWS due to increased clearance of vWF [abstract]","volume":"86","author":"Scott","year":"1995","journal-title":"Blood"},{"key":"10.4065\/77.2.181_bib89","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1055\/s-0037-1615235","article-title":"Quantitative analysis of von Willebrand factor and its propeptide in plasma in acquired von Willebrand syndrome","volume":"80","author":"van Genderen","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.4065\/77.2.181_bib90","first-page":"143","article-title":"The use of high-dose intravenous gamma-globulin in acquired von Willebrand syndrome","volume":"112","author":"Macik","year":"1988","journal-title":"Arch Pathol Lab Med"},{"key":"10.4065\/77.2.181_bib91","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1046\/j.1365-2141.1997.d01-1987.x","article-title":"Acquired von Willebrand disease in a patient with angiodysplasia resulting from immune-mediated clearance of von Willebrand factor","volume":"96","author":"Inbal","year":"1997","journal-title":"Br J Haematol"},{"key":"10.4065\/77.2.181_bib92","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S0025-6196(12)61203-8","article-title":"Treatment of von Willebrand's disease","volume":"66","author":"Aledort","year":"1991","journal-title":"Mayo Clin Proc"},{"issue":"suppl 1","key":"10.4065\/77.2.181_bib93","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1046\/j.1365-2516.2000.00059.x","article-title":"Desmopressin (DDAVP) in the treatment of bleeding disorders: the first twenty years","volume":"6","author":"Mannucci","year":"2000","journal-title":"Haemophilia"},{"key":"10.4065\/77.2.181_bib94","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S0022-3476(83)80526-5","article-title":"DDAVP: a useful alternative to blood components in moderate hemophilia A and von Willebrand disease","volume":"102","author":"Warrier","year":"1983","journal-title":"J Pediatr"},{"key":"10.4065\/77.2.181_bib95","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1055\/s-0038-1653887","article-title":"High-dose intravenous immunoglobulin delays clearance of von Willebrand factor in acquired von Willebrand disease","volume":"73","author":"van Genderen","year":"1995","journal-title":"Thromb Haemost"},{"key":"10.4065\/77.2.181_bib96","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1055\/s-0038-1648405","article-title":"Subunit composition of plasma von Willebrand factor (vWF) in two uremic patients with acquired vWF abnormalities","volume":"67","author":"Castaman","year":"1992","journal-title":"Thromb Haemost"},{"key":"10.4065\/77.2.181_bib97","first-page":"286","article-title":"Acquired type 2a von Willebrand's disease: response to immunoglobulin infusion","volume":"27","author":"Sampson","year":"1997","journal-title":"Haemostasis"},{"key":"10.4065\/77.2.181_bib98","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/ajh.2830410212","article-title":"Effectiveness of high-dose intravenous immunoglobulin in a case of acquired von Willebrand syndrome with chronic melena not responsive to desmopressin and factor VIII concentrate","volume":"41","author":"Castaman","year":"1992","journal-title":"Am J Hematol"},{"key":"10.4065\/77.2.181_bib99","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1046\/j.1537-2995.1991.31391165179.x","article-title":"Immunoadsorption for coagulation factor inhibitors","volume":"31","author":"Uehlinger","year":"1991","journal-title":"Transfusion"},{"key":"10.4065\/77.2.181_bib100","first-page":"1523","article-title":"Acquired von Willebrand's syndrome during autoimmune disorder","volume":"42","author":"Pizzuto","year":"1980","journal-title":"Thromb Haemost"},{"key":"10.4065\/77.2.181_bib101","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1136\/pgmj.66.776.474","article-title":"Acquired von Willebrand's disease and hypothyroidism: report of a case presenting with menorrhagia","volume":"66","author":"Blesing","year":"1990","journal-title":"Postgrad Med J"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611623331?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611623331?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T01:13:01Z","timestamp":1589505181000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619611623331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,2]]},"references-count":101,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002,2]]}},"alternative-id":["S0025619611623331"],"URL":"https:\/\/doi.org\/10.4065\/77.2.181","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2002,2]]}}}